MARKET COMPOSITE
AMRX - Amneal Pharmaceuticals Inc8:00:00 PM 3/27/2024
Price
$6.12
+ 0.27 (4.62%)
Amneal Pharmaceuticals, Inc. is a U.S.-domiciled publicly traded generics and specialty pharmaceutical company. The company is headquartered in Bridgewater, New Jersey. Amneal Pharmaceuticals was founded in 2002 by brothers Chirag and Chintu Patel. The company manufactured its first Rx product in 2005 and received its first ANDA approval in 2006.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue617MM-0%
Gross Profit189.8MM-18%
Cost Of Revenue427.2MM+10%
Operating Income14.2MM-81%
Operating Expenses175.6MM-
Net Income-101.4MM-753%
R&D46.1MM+11%
G&A109MM-4%
Amortization40.7MM+0%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news